Casimir Capital

Casimir Capital was a boutique investment bank and broker-dealer that specialized in providing capital raising and advisory services to small and mid-cap companies, with a significant focus on the healthcare, life sciences, and natural resources sectors. The firm was well-known for its research coverage of emerging biotechnology and specialty pharmaceutical companies and for hosting specialized investor conferences that connected institutional investors with healthcare executives. While it played a prominent role in financing micro-cap healthcare ventures during the 2000s and early 2010s, the firm has since ceased its primary investment banking operations. It is distinct from Casimir, LLC, a rare disease-focused clinical research organization acquired by Aetion in 2022.